276 related articles for article (PubMed ID: 6969147)
1. Immunological distinction of adult T cell leukaemia from T cell acute lymphoblastic leukaemia.
Tsubota T; Miyoshi I; Uno J; Hiraki S; Kobayashi T; Sato U; Kimura I
Clin Exp Immunol; 1980 Jul; 41(1):130-5. PubMed ID: 6969147
[TBL] [Abstract][Full Text] [Related]
2. Acute lymphoblastic leukemia (ALL) antigens detected with antisera to E rosette-froming and non-E rosette-forming ALL blasts.
Borella L; Sen L; Casper JT
J Immunol; 1977 Jan; 118(1):309-15. PubMed ID: 318669
[TBL] [Abstract][Full Text] [Related]
3. [Serological diagnosis of the antigenic markers of acute lymphatic leukaemias and non-Hodgkin lymphomas in childhood (author's transl)].
Thränhardt H; Zintl F; Plenert W
Arch Geschwulstforsch; 1978; 48(4):289-300. PubMed ID: 308796
[TBL] [Abstract][Full Text] [Related]
4. Human leukaemia-associated antigens expressed by acute lymphocytic leukaemias and their detection with heterologous antisera to T, B-, and non-T-non-B subtype AL blasts.
Thränhardt H; Milleck J; Zintl F; Plenert W; Koppitz D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(3):321-40. PubMed ID: 89983
[TBL] [Abstract][Full Text] [Related]
5. Use of stimulating capacity of mixed lymphocyte reaction (MLR-S) as a possible marker for the cell-origin of null-cell acute lymphoblastic leukaemia.
Han T; Minowada J
Immunology; 1978 Aug; 35(2):333-9. PubMed ID: 155647
[TBL] [Abstract][Full Text] [Related]
6. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.
Han T; Gomez GA; Minowada J
Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646
[TBL] [Abstract][Full Text] [Related]
7. Reactivity of antihuman thymocyte serum with acute leukemic blasts.
Mills B; Sen L; Borella L
J Immunol; 1975 Oct; 115(4):1038-44. PubMed ID: 1100719
[TBL] [Abstract][Full Text] [Related]
8. Separation of T lymphocytes from normal individuals and patients with B lymphocyte chronic lymphocytic leukaemia.
Fernandez LA; MacSween JM; Langley GR
Immunology; 1975 Feb; 28(2):231-41. PubMed ID: 1091543
[TBL] [Abstract][Full Text] [Related]
9. Receptors for Helix pomatia A haemagglutinin on leukaemic lymphocytes from patients with chronic lymphocytic leukaemia (CLL).
Hellstrom U; Mellstedt H; Perlmann P; Holm G; PETTERSSON D
Clin Exp Immunol; 1976 Nov; 26(2):196-203. PubMed ID: 1086751
[TBL] [Abstract][Full Text] [Related]
10. Acute lymphoblastic leukaemia of the B-cell type refractory to intensive chemotherapy.
Kawashima K; Morishima Y; Kato Y; Takeyama H; Kobayashi M; Suzuki K; Ueda R; Yamada K; Naito K; Yoshikawa S; Sako F
Clin Exp Immunol; 1978 Mar; 31(3):448-55. PubMed ID: 306904
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte immunological patterns in leukaemia: a review.
Atsaldi G; Astaldi GC; Topuz U; Guarina L
Haematologia (Budap); 1975; 9(1-2):21-33. PubMed ID: 780227
[TBL] [Abstract][Full Text] [Related]
12. [Immunological classification of acute lymphoblastic leukemias (author's transl)].
Tubiana N; Derre M; Carcassonne Y
Sem Hop; 1980 Dec 18-25; 56(47-68):1993-7. PubMed ID: 6256912
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody SN2 defining a human T cell leukemia-associated cell surface glycoprotein.
Seon BK; Negoro S; Barcos MP; Tebbi CK; Chervinsky D; Fukukawa T
J Immunol; 1984 Apr; 132(4):2089-95. PubMed ID: 6607954
[TBL] [Abstract][Full Text] [Related]
14. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.
Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS
J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206
[TBL] [Abstract][Full Text] [Related]
15. Rabbit antiserum against a non-T, non-B leukemia cell line that carries the Ph1 chromosome (NALM-1): antibody specific to a non-T, non-B acute lymphoblastic leukemia antigen.
Koshiba H; Minowada J; Pressman D
J Natl Cancer Inst; 1978 Oct; 61(4):987-91. PubMed ID: 81309
[TBL] [Abstract][Full Text] [Related]
16. Cell surface markers in chronic lymphotic leukaemia.
Poros A; Mód A
Acta Med Acad Sci Hung; 1977; 34(3):99-107. PubMed ID: 311131
[TBL] [Abstract][Full Text] [Related]
17. Surface antigenic specificities of human thymus-derived lymphocytes.
Ishii Y; Koshiba H; Ueno H; Imai K; Kikuchi K
Clin Exp Immunol; 1975 Jan; 19(1):67-74. PubMed ID: 54232
[TBL] [Abstract][Full Text] [Related]
18. [Subtypification of acute lymphocytic leukaemia (ALL) in childhood by characterization of immunological surface membrane markers (author's transl)].
Thränhardt H; Milleck J; Zintl F; Schöntube M; Jantscheff P; Plenert W
Arch Geschwulstforsch; 1980; 50(3):243-52. PubMed ID: 7002091
[TBL] [Abstract][Full Text] [Related]
19. Antigen heterogeneity of human B and T lymphocytes.
Rabellino EM; Grey HM; LaForge S; Pirofsky B; Kashiwagi N; Malley A
J Clin Invest; 1976 Feb; 57(2):390-7. PubMed ID: 815274
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of T lymphocytes by protein A from Staphylococcus aureus in B-derived chronic lymphocytic leukaemia.
Guglielmi P; Preud'Homme JL
Clin Exp Immunol; 1980 Jul; 41(1):136-40. PubMed ID: 6969148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
